Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Total Liabilities (2016 - 2026)

Orthopediatrics has reported Total Liabilities over the past 12 years, most recently at $163.5 million for Q1 2026.

  • For Q1 2026, Total Liabilities rose 32.8% year-over-year to $163.5 million; the TTM value through Mar 2026 reached $163.5 million, up 32.8%, while the annual FY2025 figure was $162.0 million, 36.57% up from the prior year.
  • Total Liabilities for Q1 2026 was $163.5 million at Orthopediatrics, up from $162.0 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $163.5 million in Q1 2026 and troughed at $46.7 million in Q3 2022.
  • A 5-year average of $95.1 million and a median of $86.0 million in 2022 define the central range for Total Liabilities.
  • Biggest five-year swings in Total Liabilities: plummeted 47.4% in 2023 and later surged 149.03% in 2025.
  • Year by year, Total Liabilities stood at $49.1 million in 2022, then grew by 25.76% to $61.7 million in 2023, then surged by 92.23% to $118.6 million in 2024, then soared by 36.57% to $162.0 million in 2025, then increased by 0.89% to $163.5 million in 2026.
  • Business Quant data shows Total Liabilities for KIDS at $163.5 million in Q1 2026, $162.0 million in Q4 2025, and $144.2 million in Q3 2025.